{"SPADE_UN_13945": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_13945", "Peptide Name": "4318(derived from the RNase H domain of HIV-1 RT (20-mes)),65(derived from the HIV-1 HXB2 Pol region of the viral genome)", "Source": "Synthetic construct(derived from HIV-1 Reverse Transcriptase)", "Family": "Retroviridae", "Gene": "Not found", "Sequence": "LQDSGLEVNIVTDSQYALGI", "Sequence Length": 20, "UniProt Entry": "No entry found", "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Antiviral"], "Target Organism": "[Ref.16879966]HIV:inhibition of 3′-processing catalyzed by wild-type integrase(IC50=11±1 µM);inhibition of strand transfer catalyzed by wild-type integrase(IC50=2±1 µM);inhibition of 3′-processing catalyzed by soluble mutant integrase(IC50>167 µM);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=36±14 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=18±3 µM);inhibition of strand transfer catalyzed by C130S integrase(IC50=4±1 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50>167 µM);inhibition of strand transfer catalyzed by C130A integrase(IC50=20 µM).NOTE:soluble mutant,C130S,C130S integrase are mutant IN.", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry", "Binding Target": "Integrase", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C93H151N23O34", "Mass": 2135.33, "PI": 4.05, "Net Charge": -3, "Hydrophobicity": 0.26, "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min", "Mechanism of action": "Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.", "Literature": [{"Title": "Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.", "Pubmed ID": "15790559", "Reference": "J Biol Chem. 2005 Jun 10;280(23)21987-96.", "Author": "Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15790559"}, {"Title": "Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome.", "Pubmed ID": "16879966", "Reference": "Bioorg Med Chem Lett. 2006 Oct 1;16(19)5199-202.", "Author": "Zawahir Z, Neamati N.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16879966"}], "Frequent Amino Acids": "LDG", "Absent Amino Acids": "CFHKMOPRUW", "Basic Residues": 0, "Acidic Residues": 3, "Hydrophobic Residues": 9, "Polar Residues": 10, "Positive Residues": 0, "Negative Residues": 3, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_13944", "Similarity": 1.0, "Sequence": "KTELQAIYLALQDSGLEVNI"}, {"SPADE_ID": "SPADE_UN_13946", "Similarity": 1.0, "Sequence": "VTDSQYALGIIQAQPDQSES"}]}}}